by Sue Robbins | Nov 12, 2020 | Migraine
Novartis announced positive results from a phase 4 study comparing treatment with erenumab (Aimovig), a calcitonin gene-related peptide (CGRP) receptor antagonist, to topiramate in patients with episodic and chronic migraine. The randomized, double-blind,...
by Sue Robbins | Jun 22, 2015 | Headache Drugs
A recent report has raised concerns that the drug topiramate, which the FDA recently approved for migraine prevention, may increase the risk of eating disorders in some teens. Jocelyn Lebow, PhD, a child and adolescent psychologist at the University of Miami Miller...
by Jeff Poleet | May 15, 2012 | Headache Drugs, Miscellaneous
This is a post taken from excerpts from comments I shared between another migraine patient and I in regards to preventive migraine treatment. I wanted to share it in a blog post, as I didn’t want the information to be overlooked in the comments section. With that...
by Dr Robbins | Oct 12, 2011 | Headache Drugs
A study conducted at the University of Gothenburg, Sweden studied migraine patients and determined that exercise can prevent migraines, in some cases as well as drugs or relaxation techniques. Lead study author Emma Varkey and colleagues evaluated 91 migraine...
by Dr Robbins | Dec 9, 2002 | Headache Drugs
A recent study investigated this important subject; even if a headache med. works, nobody is happy if they gain 30lb. Surprisingly, Prozac topped the list of weight gainers; even more than the tricyclic nortryptylline. Depakote did, as we know, cause weight gain,...